Eton Pharmaceuticals, Inc.

NASDAQ:ETON

5.15 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -0.936-9.021-1.955-27.97-18.32-12.74-7.156
Depreciation & Amortization 0.9011.7740.4620.6510.4470.0630.013
Deferred Income Tax 00-0.5460000
Stock Based Compensation 3.1374.2183.3812.5761.8881.852.642
Change In Working Capital 3.5967.723-6.2111.012-2.0570.0990.623
Accounts Receivables -1.5593.619-5.4230.425-0.47300
Inventory -0.354-0.0070.692-0.862-0.3800
Accounts Payables 0.053-0.008-0.571.769-0.3770.4130.539
Other Working Capital 5.4564.119-0.91-0.32-0.827-0.3140.084
Other Non Cash Items 6.9160.1270.1481.3850.0162.5831.289
Operating Cash Flow 6.8154.821-4.721-22.346-18.026-8.145-4.718
Investing Activities:
Investments In Property Plant And Equipment -0.775-2.788-3.259-0.05-1.846-0.236-0.13
Acquisitions Net 000.70000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites -0.775-2.75-2.550-0.7500
Investing Cash Flow -0.775-2.788-2.559-0.05-1.846-0.236-0.13
Financing Activities:
Debt Repayment -1.155-0.385-0.15-2.476-4.7500
Common Stock Issued 0.1980.2510.54128.7820.22622.80318.004
Common Stock Repurchased 0000000
Dividends Paid 00000-1.0480
Other Financing Activities 0.1980.2510.5415.3199.7270.20527.006
Financing Cash Flow -0.957-0.1340.39131.6255.20321.9618.004
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 5.0831.899-6.8899.229-14.66913.57913.156
Cash At End Of Period 21.38816.30514.40621.29512.06626.73513.156